This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

reputable news agency


Aerobic exercise cuts chemotherapy-induced peripheral neuropathy symptoms

Aerobic exercise cuts chemotherapy-induced peripheral neuropathy symptoms

A six-month aerobic exercise intervention significantly improves self-reported chemotherapy-induced peripheral neuropathy (CIPN) among patients treated for ovarian cancer, according to a study published online Aug. 1 in JAMA Network Open.

Anlan Cao, M.B.B.S., from Yale University in New Haven, Connecticut, and colleagues evaluated the effect of a six-month aerobic exercise intervention on CIPN among women treated for ovarian cancer. The analysis included 134 participants in the Women's Activity and Lifestyle Study in Connecticut (65 controls).

The researchers found that at six months, the self-reported CIPN score was 1.3 points lower in the exercise intervention arm (95 percent confidence interval, −2.3 to −0.2) versus an increase of 0.4 points in the attention control arm (95 percent confidence interval, −0.8 to 1.5). The between-group difference was −1.6 (95 percent confidence interval, −3.1 to −0.2). Among participants with CIPN symptoms at baseline, the point estimate was larger (−2.0; 95 percent confidence interval, −3.6 to −0.5).

"While replication of the findings in other studies is warranted, incorporating referrals to exercise programs into standard oncology care could reduce CIPN symptoms and increase quality of life in patients with ," the authors write.

More information: Anlan Cao et al, Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer, JAMA Network Open (2023). DOI: 10.1001/jamanetworkopen.2023.26463

Journal information: JAMA Network Open

Copyright © 2023 HealthDay. All rights reserved.

Citation: Aerobic exercise cuts chemotherapy-induced peripheral neuropathy symptoms (2023, August 2) retrieved 5 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Multivitamin use may cut risk of chemo-induced neuropathy


Feedback to editors